ENTRY       D11881                      Drug
NAME        Amlodipine benzoate;
            Katerzia (TN)
PRODUCT     KATERZIA (Azurity Pharmaceuticals)
  GENERIC   AMLODIPINE (Amneal Pharmaceuticals NY LLC)
FORMULA     C20H25ClN2O5. C7H6O2
EXACT_MASS  530.182
MOL_WEIGHT  530.9972
CLASS       Cardiovascular agent
             DG01575  Calcium channel blocker
              DG01496  Calcium channel L type blocker
             DG03231  Antihypertensive
              DG01928  Dihydropyridine calcium channel blocker
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      ATC code: C08CA01
            Chemical structure group: DG00322
            Product (DG00322): D00615<JP/US> D11881<US>
EFFICACY    Antihypertensive, Vasodilator, Calcium channel blocker
  DISEASE   Hypertension [DS:H01633]
            Coronary artery disease [DS:H01742]
TARGET      CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]
  PATHWAY   hsa04020(775+776+778+779)  Calcium signaling pathway
            hsa04260(775+776+778+779)  Cardiac muscle contraction
            hsa04261(775+776+778+779)  Adrenergic signaling in cardiomyocytes
            hsa04270(775+776+778+779)  Vascular smooth muscle contraction
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C08 CALCIUM CHANNEL BLOCKERS
               C08C SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS
                C08CA Dihydropyridine derivatives
                 C08CA01 Amlodipine
                  D11881  Amlodipine benzoate &lt;US&gt;
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01575  Calcium channel blocker
               DG01496  Calcium channel L type blocker
                DG00322  Amlodipine
                 D11881  Amlodipine benzoate
              DG03231  Antihypertensive
               DG01928  Dihydropyridine calcium channel blocker
                DG00322  Amlodipine
                 D11881  Amlodipine benzoate
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00322  Amlodipine
                 D11881  Amlodipine benzoate
            Drug classes [BR:br08332]
             Cardiovascular agent
              DG01928  Dihydropyridine calcium channel blocker
               D11881  Amlodipine benzoate
              DG03231  Antihypertensive
               D11881  Amlodipine benzoate
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Voltage-gated ion channels
               Calcium channels
                CACNA1-L
                 D11881  Amlodipine benzoate &lt;US&gt;
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D11881
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01575  Calcium channel blocker
               DG01496  Calcium channel L type blocker
                DG00322  Amlodipine
              DG03231  Antihypertensive
               DG01928  Dihydropyridine calcium channel blocker
                DG00322  Amlodipine
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00322  Amlodipine
ATOM        37
            1   C1y C    17.5124  -15.0607
            2   C2y C    18.7032  -14.3602
            3   C2y C    16.3215  -14.3602
            4   C8y C    17.5124  -17.3723
            5   C2y C    18.7032  -12.9592
            6   C7a C    19.8941  -15.0607
            7   C2y C    16.3215  -12.9592
            8   C7a C    15.1307  -14.9906
            9   C8y C    18.7032  -18.0728
            10  C8x C    16.3215  -18.0728
            11  N1x N    17.5124  -12.2587
            12  C1b C    19.8941  -12.2587
            13  O7a O    21.0849  -14.3602
            14  O6a O    19.8941  -16.3215
            15  C1a C    15.1307  -12.2587
            16  O7a O    13.9399  -14.3602
            17  O6a O    15.1307  -16.3215
            18  C8x C    18.7032  -19.4037
            19  X   Cl   19.8941  -17.3723
            20  C8x C    16.3215  -19.4037
            21  O2a O    21.0849  -12.9592
            22  C1b C    22.2758  -15.0607
            23  C1a C    12.7490  -14.9906
            24  C8x C    17.5124  -20.1042
            25  C1b C    22.2758  -12.2587
            26  C1a C    23.4666  -14.3602
            27  C1b C    23.4666  -12.9592
            28  N1a N    24.5874  -12.2587
            29  C8x C    26.2500  -18.0600
            30  C8x C    26.2500  -19.4600
            31  C8x C    27.4624  -20.1600
            32  C8x C    28.6749  -19.4600
            33  C8x C    28.6749  -18.0600
            34  C8y C    27.4624  -17.3600
            35  C6a C    27.4624  -15.9602
            36  O6a O    26.2332  -15.2503
            37  O6a O    28.6580  -15.2698
BOND        38
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     2   5 2
            5     2   6 1
            6     3   7 2
            7     3   8 1
            8     4   9 1
            9     4  10 2
            10    5  11 1
            11    5  12 1
            12    6  13 1
            13    6  14 2
            14    7  15 1
            15    8  16 1
            16    8  17 2
            17    9  18 2
            18    9  19 1
            19   10  20 1
            20   12  21 1
            21   13  22 1
            22   16  23 1
            23   18  24 1
            24   21  25 1
            25   22  26 1
            26   25  27 1
            27   27  28 1
            28    7  11 1
            29   20  24 2
            30   29  30 2
            31   30  31 1
            32   31  32 2
            33   32  33 1
            34   33  34 2
            35   29  34 1
            36   34  35 1
            37   35  36 2
            38   35  37 1
///
